Cigna Investments’s Lam Research LRCX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $5.1M | Sell |
11,768
-193
| -2% | -$58.6K | 0.66% | 25 |
|
|
2026
Q1 | $2.56M | Sell |
11,961
-195
| -2% | -$43.6K | 0.39% | 40 |
|
|
2025
Q4 | $2.08M | Sell |
12,156
-289
| -2% | -$44.9K | 0.3% | 51 |
|
|
2025
Q3 | $1.67M | Sell |
12,445
-113
| -0.9% | -$12K | 0.23% | 68 |
|
|
2025
Q2 | $1.22M | Sell |
12,558
-371
| -3% | -$29.4K | 0.21% | 96 |
|
|
2025
Q1 | $940K | Sell |
12,929
-297
| -2% | -$23.4K | 0.17% | 122 |
|
|
2024
Q4 | $955K | Sell |
13,226
-264
| -2% | -$20K | 0.17% | 115 |
|
|
2024
Q3 | $1.1M | Sell |
13,490
-90
| -0.7% | -$7.83K | 0.19% | 105 |
|
|
2024
Q2 | $1.45M | Sell |
13,580
-400
| -3% | -$38.4K | 0.27% | 68 |
|
|
2024
Q1 | $1.36M | Sell |
13,980
-40
| -0.3% | -$3.52K | 0.26% | 77 |
|
|
2023
Q4 | $1.1M | Sell |
14,020
-380
| -3% | -$25.9K | 0.23% | 96 |
|
|
2023
Q3 | $903K | Sell |
14,400
-2,020
| -12% | -$133K | 0.21% | 106 |
|
|
2023
Q2 | $1.06M | Hold |
16,420
| – | – | 0.2% | 105 |
|
|
2023
Q1 | $870K | Sell |
16,420
-560
| -3% | -$27.5K | 0.17% | 119 |
|
|
2022
Q4 | $713K | Buy |
16,980
+30
| +0.2% | +$1.25K | 0.15% | 148 |
|
|
2022
Q3 | $620K | Sell |
16,950
-1,040
| -6% | -$46.3K | 0.14% | 156 |
|
|
2022
Q2 | $767K | Sell |
17,990
-6,860
| -28% | -$327K | 0.15% | 141 |
|
|
2022
Q1 | $1.34M | Sell |
24,850
-7,180
| -22% | -$418K | 0.16% | 121 |
|
|
2021
Q4 | $2.3M | Sell |
32,030
-11,650
| -27% | -$730K | 0.18% | 97 |
|
|
2021
Q3 | $2.49M | Sell |
43,680
-1,170
| -3% | -$71.2K | 0.19% | 102 |
|
|
2021
Q2 | $2.92M | Sell |
44,850
-7,300
| -14% | -$461K | 0.21% | 93 |
|
|
2021
Q1 | $3.1M | Buy |
52,150
+660
| +1% | +$36K | 0.21% | 94 |
|
|
2020
Q4 | $2.43M | Buy |
51,490
+3,610
| +8% | +$152K | 0.19% | 105 |
|
|
2020
Q3 | $1.59M | Sell |
47,880
-60
| -0.1% | -$2.07K | 0.15% | 134 |
|
|
2020
Q2 | $1.55M | Buy |
47,940
+6,380
| +15% | +$174K | 0.15% | 139 |
|
|
2020
Q1 | $998K | Buy |
41,560
+2,500
| +6% | +$72K | 0.13% | 183 |
|
|
2019
Q4 | $1.16M | Sell |
39,060
-4,790
| -11% | -$127K | 0.12% | 214 |
|
|
2019
Q3 | $1.19M | Buy |
43,850
+1,500
| +4% | +$31.5K | 0.12% | 217 |
|
|
2019
Q2 | $884K | Sell |
42,350
-3,450
| -8% | -$65.5K | 0.1% | 257 |
|
|
2019
Q1 | $821K | Sell |
45,800
-270
| -0.6% | -$4.5K | 0.09% | 268 |
|
|
2018
Q4 | $628K | Sell |
46,070
-570
| -1% | -$8.17K | 0.05% | 270 |
|
|
2018
Q3 | $660K | Sell |
46,640
-6,460
| -12% | -$110K | 0.05% | 280 |
|
|
2018
Q2 | $917K | Sell |
53,100
-6,840
| -11% | -$132K | 0.07% | 256 |
|
|
2018
Q1 | $1.22M | Sell |
59,940
-90
| -0.1% | -$1.78K | 0.08% | 222 |
|
|
2017
Q4 | $1.1M | Sell |
60,030
-2,430
| -4% | -$47.8K | 0.07% | 224 |
|
|
2017
Q3 | $1.16M | Sell |
62,460
-630
| -1% | -$10.2K | 0.08% | 209 |
|
|
2017
Q2 | $892K | Sell |
63,090
-4,550
| -7% | -$66.7K | 0.06% | 278 |
|
|
2017
Q1 | $868K | Buy |
67,640
+7,830
| +13% | +$92K | 0.06% | 304 |
|
|
2016
Q4 | $632K | Buy |
+59,810
| New | +$607K | 0.07% | 347 |
|
Other funds holding LRCX
Cigna Investments's LRCX Position: Q2 2026 in Review
Cigna Investments reduced its Lam Research (LRCX) stake by 1.6% in Q2 2026, selling an estimated $58.6K and leaving 11,768 shares worth $5.1M. The position accounts for 0.66% of the portfolio, ranked #25.
Cigna Investments first reported a position in LRCX in Q4 2016 and has held it in 39 quarters since. 3,123 funds tracked by Wall St. Rank hold LRCX as of Q2 2026.
- Cigna Investments held 11,768 shares of Lam Research worth $5.1M as of Q2 2026.
- Cigna Investments sold 193 Lam Research shares in Q2 2026, an estimated $58.6K.
- Lam Research made up 0.66% of Cigna Investments's portfolio in Q2 2026, its #25 holding.
- Cigna Investments first reported a position in Lam Research in Q4 2016 and has held it in 39 quarters since.
- 3,123 funds tracked by Wall St. Rank held Lam Research as of Q2 2026.
Based on Cigna Investments's 13F filing for Q2 2026, filed 21 Jul 2026.